AXSOME THERAPEUTICS, INC. Shareholders' Equity
AXSOME THERAPEUTICS, INC. (AXSM) had Shareholders' Equity of $83.30 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $83.30M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $54.59M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $88.30M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $73.73M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $83.30M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $54.59M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $88.30M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $73.73M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $73.08M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $53.20M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $57.02M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $92.90M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $102.85M 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $144.04M 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $190.98M 10-K · filed 2026-02-23 | |
| 2023-09-30 | $269.51M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $278.80M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $111.81M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $109.56M 10-K · filed 2026-02-23 | $109.56M 10-K · filed 2023-02-28 |
| 2022-09-30 | $157.36M 10-Q · filed 2023-11-06 | $157.36M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $15.20M 10-Q · filed 2023-11-06 | $15.20M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $14.70M 10-Q · filed 2023-11-06 | $14.70M 10-Q · filed 2022-05-02 |
| 2021-12-31 | $15.63M 10-K · filed 2025-02-18 | $15.63M 10-K · filed 2022-03-01 |
| 2021-09-30 | $42.72M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $71.44M 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $96.29M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $113.79M 10-K · filed 2024-02-23 | $113.79M 10-K · filed 2021-03-01 |
| 2020-09-30 | $135.26M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $154.24M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $156.16M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $178.72M 10-K · filed 2023-02-28 | |
| 2019-09-30 | $6.82M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $24.28M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $17.37M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $937.92K 10-K · filed 2022-03-01 | |
| 2018-09-30 | $742.76K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $7.01M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $12.59M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $16.72M 10-K · filed 2021-03-01 | |
| 2017-09-30 | $16.84M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $22.75M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $29.28M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $21.57M 10-K · filed 2020-03-12 | |
| 2016-09-30 | $28.18M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $34.90M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $41.23M 10-Q/A · filed 2016-08-09 | |
| 2015-12-31 | $46.44M 10-K · filed 2019-03-15 | |
| 2014-12-31 | -$3.20M 10-K · filed 2018-03-07 | |
| 2013-12-31 | -$2.03M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |